Figure 3 | Scientific Reports

Figure 3

From: Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

Figure 3

Kaplan–Meier estimates of MFS as a function of mGluR1 expression in ER-negative breast cancer and TNBC. Kaplan–Meier estimates of MFS: (a) ER-negative breast cancer; and (b) TNBC. Patients were divided into two groups based on mGluR1 expression. Positive mGluR1 expression is depicted in dark blue lines and negative mGluR1 expression is depicted in light blue lines.

Back to article page